211 related articles for article (PubMed ID: 21569373)
1. The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.
Lips DJ; Koebrugge B; Liefers GJ; van de Linden JC; Smit VT; Pruijt HF; Putter H; van de Velde CJ; Bosscha K
BMC Surg; 2011 May; 11():11. PubMed ID: 21569373
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the detection of lymph node micrometastases in colon cancer.
Bosch Roig CE; Roselló-Sastre E; Alonso Hernández S; Almenar Cubells D; Grau Cardona E; Camarasa Lillo N; Bautista D; Molins Palau C
Clin Transl Oncol; 2008 Sep; 10(9):572-8. PubMed ID: 18796374
[TBL] [Abstract][Full Text] [Related]
3. United States Military Cancer Institute Clinical Trials Group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer.
Nissan A; Protic M; Bilchik AJ; Howard RS; Peoples GE; Stojadinovic A
Ann Surg; 2012 Sep; 256(3):412-27. PubMed ID: 22871988
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of histological superstudy of sentinel lymph nodes detected with radioisotopes in colon cancer.
Serrano Del Moral Á; Pérez Viejo E; Castaño Pascual Á; Llorente Herrero E; Rodríguez Caravaca G; Duran Poveda M; Pereira Pérez F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(6):358-366. PubMed ID: 34752369
[TBL] [Abstract][Full Text] [Related]
5. Challenging the conventional treatment of colon cancer by sentinel lymph node mapping and its role of detecting micrometastases for adjuvant chemotherapy.
Saha S; Elgamal M; Cherry M; Buttar R; Pentapati S; Mukkamala S; Devisetty K; Kaushal S; Alnounou M; Singh T; Grewal S; Eilender D; Arora M; Wiese D
Clin Exp Metastasis; 2018 Aug; 35(5-6):463-469. PubMed ID: 30116938
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Bilchik AJ; Hoon DS; Saha S; Turner RR; Wiese D; DiNome M; Koyanagi K; McCarter M; Shen P; Iddings D; Chen SL; Gonzalez M; Elashoff D; Morton DL
Ann Surg; 2007 Oct; 246(4):568-75; discussion 575-7. PubMed ID: 17893493
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial.
Bembenek AE; Rosenberg R; Wagler E; Gretschel S; Sendler A; Siewert JR; Nährig J; Witzigmann H; Hauss J; Knorr C; Dimmler A; Gröne J; Buhr HJ; Haier J; Herbst H; Tepel J; Siphos B; Kleespies A; Koenigsrainer A; Stoecklein NH; Horstmann O; Grützmann R; Imdahl A; Svoboda D; Wittekind C; Schneider W; Wernecke KD; Schlag PM
Ann Surg; 2007 Jun; 245(6):858-63. PubMed ID: 17522509
[TBL] [Abstract][Full Text] [Related]
9. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
10. Molecular staging of lymph node-negative colon carcinomas by one-step nucleic acid amplification (OSNA) results in upstaging of a quarter of patients in a prospective, European, multicentre study.
Croner RS; Geppert CI; Bader FG; Nitsche U; Späth C; Rosenberg R; Zettl A; Matias-Guiu X; Tarragona J; Güller U; Stürzl M; Zuber M
Br J Cancer; 2014 May; 110(10):2544-50. PubMed ID: 24722182
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of sentinel lymph node biopsy for staging, treatment and prognosis of colon and gastric cancer.
Dragan R; Nebojsa M; Dejan S; Ivan P; Dragos S; Damir J; Predrag S; Vladan Z
Hepatogastroenterology; 2009; 56(96):1606-11. PubMed ID: 20214202
[TBL] [Abstract][Full Text] [Related]
12. Detection of micrometastases and skip metastases with ex vivo sentinel node mapping in carcinoma of the colon and rectum.
Yagci G; Unlu A; Kurt B; Can MF; Kaymakcioglu N; Cetiner S; Tufan T; Sen D
Int J Colorectal Dis; 2007 Feb; 22(2):167-73. PubMed ID: 16721490
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
15. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Bilchik AJ; DiNome M; Saha S; Turner RR; Wiese D; McCarter M; Hoon DS; Morton DL
Arch Surg; 2006 Jun; 141(6):527-33; discussion 533-4. PubMed ID: 16785352
[TBL] [Abstract][Full Text] [Related]
16. Stage migration in breast cancer: surgical decisions concerning isolated tumour cells and micro-metastases in the sentinel lymph node.
de Widt-Levert L; Tjan-Heijnen V; Bult P; Ruers T; Wobbes T
Eur J Surg Oncol; 2003 Apr; 29(3):216-20. PubMed ID: 12657229
[TBL] [Abstract][Full Text] [Related]
17. GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.
Mejia A; Schulz S; Hyslop T; Weinberg DS; Waldman SA
Expert Rev Mol Diagn; 2009 Nov; 9(8):777-85. PubMed ID: 19895223
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node mapping for adenocarcinoma of the colon does not improve staging accuracy.
Read TE; Fleshman JW; Caushaj PF
Dis Colon Rectum; 2005 Jan; 48(1):80-5. PubMed ID: 15690662
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.
Nordgård O; Oltedal S; Aasprong OG; Søreide JA; Søreide K; Tjensvoll K; Gilje B; Heikkilä R; Guriby M; Lothe RA; Smaaland R; Kørner H
Ann Surg Oncol; 2012 Nov; 19(12):3719-26. PubMed ID: 22752373
[TBL] [Abstract][Full Text] [Related]
20. Micrometastases or isolated tumor cells and the outcome of breast cancer.
de Boer M; van Deurzen CH; van Dijck JA; Borm GF; van Diest PJ; Adang EM; Nortier JW; Rutgers EJ; Seynaeve C; Menke-Pluymers MB; Bult P; Tjan-Heijnen VC
N Engl J Med; 2009 Aug; 361(7):653-63. PubMed ID: 19675329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
